Assessing personalized risks in Neurofibromatosis Type 1
Personalized risk assessment in Neurofibromatosis Type 1
This study is looking at Neurofibromatosis Type 1 (NF1) to create smart tools that help doctors understand and predict health issues related to NF1, so they can provide better care and support for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11055330 on NIH RePORTER |
What this research studies
This research focuses on Neurofibromatosis Type 1 (NF1), a genetic disorder that can lead to various tumors and health complications. The study aims to develop artificial intelligence-based tools to better understand and predict the clinical features and risks associated with NF1. By analyzing individual patient data, the research seeks to create more accurate risk assessments and improve management strategies for those affected by NF1. This approach aims to shift from reactive to proactive care, enhancing the quality of life for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Neurofibromatosis Type 1, regardless of age, who are seeking better management of their condition.
Not a fit: Patients without a diagnosis of Neurofibromatosis Type 1 or those with other unrelated conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective management strategies for individuals with Neurofibromatosis Type 1.
How similar studies have performed: Previous research has shown promise in using artificial intelligence for clinical decision-making in other genetic disorders, suggesting potential success for this novel approach in NF1.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Gupta, Aditi — Washington University
- Study coordinator: Gupta, Aditi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.